Atlas FDA

Elecsys Anti-SARS-CoV-2

FDA 510(k) clearance K250768 · decided 2025-06-10

Clearance details

K-number
K250768
Device name
Elecsys Anti-SARS-CoV-2
Applicant
Roche Diagnostics
Decision
Substantially Equivalent
Date received
2025-03-13
Decision date
2025-06-10
Days to decision
89 days
Clearance type
Traditional
Product code
QVP
Device class
2
Regulation number
866.3983
Medical specialty
Microbiology
Advisory committee
Microbiology
Location
Indianapolis, IN, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Roche Diagnostics

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Elecsys Anti-SARS-CoV-2 S (K252280)Roche Diagnostics2026-04-13
Elecsys Anti-SARS-CoV-2 (K253839)Roche Diagnostics2025-12-17
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Calibrators (DEN210040)Ortho-Clinical Diagnostics, Inc.2023-05-05
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack, VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Calibrator (DEN210038)Ortho-Clinical Diagnostics, Inc.2023-05-05

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S010)Roche Diagnostics2025-05-22
Elecsys Anti-HBe (P190005/S007)Roche Diagnostics2025-05-22
Elecsys Anti-HBe (P190005/S006)Roche Diagnostics2024-10-03
Elecsys Anti-HBs / Elecsys HBs II (P190034/S009)Roche Diagnostics2024-10-03
Elecsys Anti-HBs II (P190034/S008)Roche Diagnostics2024-08-29
Elecsys Anti-HBe (P190005/S005)Roche Diagnostics2024-08-29
Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S007)Roche Diagnostics2024-07-23
Elecsys Anti-HBs II, PreciControl Anti-HBs (P190034/S005)Roche Diagnostics2024-05-01